Navigation Links
Alfred Mann Foundation for Biomedical Engineering Launches New Web Site Designed to Help University Researchers Bring Biomedical Advances to Market
Date:12/2/2008

VALENCIA, Calif., Dec. 2 /PRNewswire/ -- The Alfred E. Mann Foundation for Biomedical Engineering (AEMFBE), a philanthropic organization created by billionaire Alfred E. Mann to establish university-based commercialization- enablement institutes at elite universities, designed to facilitate biomedical product development for the benefit of society, today announced the launch of a Web site (http://www.mannfbe.org).

Features of the web site include:

-- Overview of Alfred Mann Institutes for Biomedical Development (AMIs), including the infrastructure and process that are created by the minimum of $100 million endowment to establish each Institute. To date, three Alfred Mann Institutes have been endowed: University of Southern California (Los Angeles), which became operational in 2001 as a test-bed for the development for future AMIs; the Technion (Haifa, Israel), 2007; and Purdue University (West Lafayette, Indiana.), 2008.

-- Background and accomplishments of Mr. Mann, who has dedicated most of his career to bettering the quality of life for those who suffer from life debilitating disorders through the development of innovative medical devices.

-- "Commercialize Your Idea," which provides insight into the developmental steps for a biomedical technology including proof of concept, FDA regulatory approval, reimbursement strategies, technology licensing considerations, etc., with an emphasis toward researchers involved in this space.

"The AMI concept has drawn a phenomenal response, both nationally and internationally, as a new model for technology transfer, a form of venture philanthropy," said A. Stephen Dahms, Ph.D., President and CEO of the AEMFBE. "The Web site addresses researchers' frequently asked questions and provides an overview of the AMI selection and creation process."

About Alfred Mann

Alfred Mann's philanthropic mission is to create and expedite the delivery of life-improving biomedical products to patients. Mann is chairman of the boards of directors for the Alfred Mann Institutes for Biomedical Development at USC, Purdue and the Technion. Mann also is chairman and chief executive officer of MannKind Corp.; chairman of Advanced Bionics Corp, Second Sight LLC, Bioness Inc., Quallion LLC and Implanted Acoustics; and chairman emeritus of Pacesetter System Inc. and MiniMed. All of these highly successful companies were founded by Mann.

About the Mann Foundation for Biomedical Engineering

Headquartered in the 167-acre Mann Biomedical Park in Valencia, Calif., the Alfred Mann Foundation for Biomedical Engineering (AEMFBE) is a philanthropic organization that establishes university-based institutes (AMIs) designed to enable biomedical product development for the benefit of mankind. The AEMFBE supports the AMIs with a variety of services, including market analysis and due diligence, valuation and exit strategy, regulatory and reimbursement guidance, cost of goods analysis and other product development activities required to expedite technologies from development to commercialization.

     Contact:

     Nancy Patterson
     Vice President
     626-993-4106
     Nancy.patterson@mannfbe.org

'/>"/>
SOURCE Alfred E. Mann Foundation for Biomedical Engineering
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Robert L. Brent, MD, PhD, Honored with 2008 Alfred I. duPont Award for Excellence in Childrens Health Care
2. HEALTHeCAREERS Network Pledges $15,000 to ASRT Foundation for Professional Healthcare Training
3. Stem Cell Sciences Enters into Services Agreement with Huntingdons Disease Research Group, CHDI Foundation Inc.
4. Amgen Foundation Announces $2.5 Million Expansion of Amgen Scholars Program to Europe
5. Medizone International, Inc. Announces Establishment of Canadian Foundation for Global Health
6. Canary Foundations Dr. Sanjiv Sam Gambhir Elected to the National Academies Institute of Medicine
7. Michael J. Fox Foundation Awards $2 Million Grant From EMD Serono to Research Projects on Cognitive Deficits in Parkinsons Disease
8. BIO Ventures for Global Health Receives $7 Million Grant from Gates Foundation to Engage Biotechnology in the Fight Against Neglected Diseases of the Developing World
9. Mirixa Corporation and the APhA Foundation Form Partnership
10. GBS/CIDP Foundation to Hold 10th International Symposium
11. Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published today ... a patient who developed lymphedema after being treated for breast cancer benefitted from an ... paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... on quality, regulatory and technical consulting, provides a free webinar on ... on July 13, 2016 at 12pm CT at no charge. , Incomplete investigations ...
Breaking Biology Technology:
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
Breaking Biology News(10 mins):